Romanian-Swiss Research Programme IZERZO

计划入组 308 人 · 首次发布于 2017 年 8 月 3 日

Swiss Neonatal Network & Follow-up Group

计划入组 1,000 人 · 首次发布于 2020 年 1 月 27 日

Chinese Research Group of Gallbladder Cancer

计划入组 10,000 人 · 首次发布于 2019 年 10 月 28 日

BRAF inhibitors(Swiss Group for Clinical Cancer Research)

Anti-EGFR-IL-dox (Swiss Group for Clinical Cancer Research)

OICR-10268

Swiss Group for Clinical Cancer Research

Switzerland

The Institute For Cancer Research

United States

The Beatson Institute For Cancer Research

United Kingdom

Intensity Therapeutics and SAKK Initiate Phase 2 Trial of INT230-6 in Triple-Negative Breast Cancer

Intensity Therapeutics' INT230-6 Shows Promise in Localized Cancer Reduction and Systemic Immune Activation

Intensity Therapeutics Secures New US Patent for Intratumoral Cancer Technology